Bloodless hip surgery at GSMCH
Tuesday, 18 March 2008
CHANDIGARH: Bloodless hip surgery would be performed at the Gian Sagar
Medical College and Hospital, near here, with an internationally acclaimed
orthopaedic surgeon Gursharan Singh Chana visiting the hospital regularly every
Disclosing this here Tuesday, Dr Sukhwinder Singh, vice-chairman of the Gian
Sagar Educational and Charitable Trust, said that Dr Chana, who is settled in
the United Kingdom, would visit the GSMCH every two months.
He would train orthopaedic surgeons in bloodless hip surgery for which a 15-day
training course would be organized every two months.
Dr Sukhwinder Singh said that Gursharan Singh Chana, a doctor of Indian origin,
would deliver a lecture on minimal invasive surgery for total hip replacement
and hip resurfacing at the Gian Sagar Medical College and Hospital on March 20.
He said that Dr Chana would interact with the faculty of the GSMCH on March 20
morning and in the evening he would address orthopaedic surgeons of Patiala. On
March 21, he would be interacting with orthopaedic surgeons of Chandigarh and on
march 22 he would have an interactive session with orthopaedicians of Ludhiana.
Dr Sukhwinder Singh said that an internationally acclaimed orthopaedic surgeon,
Dr Chana has devised a minimally invasive approach to hip joint to carry out
total hip replacement and hip resurfacing. He has devised Chana reamer handle to
allow accurate surgery of the hip joint.
Dr Chana is presently working as a consultant orthopaedic surgeon at the Royal
Orthopaedic Hospital, NHS Trust Birmingham, since October 2002.
Dr Chana has the vast experience of carrying out the over 2500 total hip
replacements, over 2000 total knee replacement, over 1500 hip resurfacing, 200
hip replacements using minimally invasive surgical approach, 200 hip
resurfacings using minimally invasive hip resurfacing.
Over the last two years he has been involved in developing instrumentation and
implants for hip resurfacing procedure to be carried out using a minimally
invasive approach through Comis Orthopaedics, a company based in Yorkshire.
The implant is being used currently in the U.K. This implant is the only one of
its kind that can be delivered using a minimally invasive approach with obvious
benefits of early discharge from hospital, blood transfusion is not necessary in
95 per cent of patients and the patients tend to return to normal activities at
an earlier stage compared to patients who undergo open surgery. The average
incision size is 7 cm. with this approach as opposed to 20 cm. using an open